QNRX
Quoin Pharmaceuticals, Ltd.
NASDAQ · Healthcare · Biotechnology · US
$3.98
+2.05%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-477.0%
Return on equity
-156.7%
Return on assets
-489.2%
Return on invested capital
0.00x
Asset turnover
-$15.4M
Cash from operations
$2.25
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026